CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-23 | Korenberg Matthew E President & COO | Option exercise · Employee Stock Option (right to buy) | −9,377 | 42,436 | ||
| 2024-09-20 | Espinoza Octavio Chief Financial Officer | Sale | −200 | $103.98 | $21K | 25,685 |
| 2024-09-20 | Espinoza Octavio Chief Financial Officer | Sale | −275 | $103.86 | $29K | 25,410 |
| 2024-09-20 | Espinoza Octavio Chief Financial Officer | Sale | −800 | $103.95 | $83K | 24,610 |
| 2024-09-20 | Korenberg Matthew E President & COO | Option exercise | +4,982 | $49.99 | $249K | 57,052 |
| 2024-09-20 | Korenberg Matthew E President & COO | Sale | −6,275 | $104.10 | $653K | 50,777 |
| 2024-09-20 | Korenberg Matthew E President & COO | Option exercise · Employee Stock Option (right to buy) | −4,982 | 395 | ||
| 2024-09-17 | Espinoza Octavio Chief Financial Officer | Option exercise | +1,417 | $80.72 | $114K | 25,816 |
| 2024-09-17 | Espinoza Octavio Chief Financial Officer | Option exercise | +69 | $57.22 | $4K | 25,885 |
| 2024-09-17 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −69 | 7,240 | ||
| 2024-09-17 | Espinoza Octavio Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −1,417 | 466 | ||
| 2024-09-16 | Korenberg Matthew E President & COO | Option exercise | +914 | $55.75 | $51K | 50,424 |
| 2024-09-16 | Korenberg Matthew E President & COO | Shares withheld for taxes | −485 | $105.00 | $51K | 49,939 |
| 2024-09-16 | Korenberg Matthew E President & COO | Option exercise | +849 | $58.49 | $50K | 50,788 |
| 2024-09-16 | Korenberg Matthew E President & COO | Shares withheld for taxes | −472 | $105.00 | $50K | 50,316 |
| 2024-09-16 | Korenberg Matthew E President & COO | Option exercise | +671 | $49.99 | $34K | 50,987 |
| 2024-09-16 | Korenberg Matthew E President & COO | Shares withheld for taxes | −319 | $105.00 | $33K | 50,668 |
| 2024-09-16 | Korenberg Matthew E President & COO | Option exercise | +3,340 | $60.94 | $204K | 54,008 |
| 2024-09-16 | Korenberg Matthew E President & COO | Shares withheld for taxes | −1,938 | $105.00 | $203K | 52,070 |
| 2024-09-16 | Korenberg Matthew E President & COO | Option exercise · Employee Stock Option (right to buy) | −671 | 5,377 |
Page 19 of 43 · 858 trades